Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases due to the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).
The Amyloidosis Center at BMC offers a multi-disciplinary approach to diagnosis and treatment of this multi-organ disorder.
Specialists in hematology-oncology, cardiology, pulmonary medicine, nephrology, gastroenterology, neurology, otolaryngology, urology, and radiation oncology participate in patient evaluation and care. The Amyloidosis Center operates a CLIA-approved diagnostic laboratory.
In the News
The segment initially aired in Syracuse, New York (WAER 88.3 FM) on NPR’s flagship news program “All Things Considered.” In observance of World Rare Disease Day, the human interest story features two patients diagnosed with systemic amyloidosis – who share their experiences from diagnosis to treatment and recovery.
Both patients were treated at Boston Medical Center. They credit their physicians for investigating abnormal tests and nonspecific symptoms, and for referring them to amyloid specialists early in the disease course. In his interview, Dr. Seldin underscores the difficulties that patients with orphan disease face, and the importance of physician awareness, early diagnosis and research.
This video highlights some of the lives Boston Medical Center has touched, including Mark Kimble, a former English teacher from Maine with amyloidosis. He was treated at Boston Medical Center with an aggressive treatment plan that included chemotherapy and stem cell transplant, first pioneered at Boston Medical Center and Boston University School of Medicine. Please click on the image below to play the video: